File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Magnesium tanshinoate B (MTB) inhibits low density lipoprotein oxidation

TitleMagnesium tanshinoate B (MTB) inhibits low density lipoprotein oxidation
Authors
KeywordsFoam cells
Low density lipoproteins (LDL)
Macrophages
Magnesium tanshinoate B (MTB)
Oxidation
Issue Date2001
PublisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/lifescie
Citation
Life Sciences, 2001, v. 68 n. 8, p. 903-912 How to Cite?
AbstractDanshen, a Chinese herbal medicine has been widely used for the treatment of cardiovascular diseases. Magnesium tanshinoate B (MTB) is an active compound purified from Danshen. The objective of this study was to investigate the effect of MTB on the susceptibility of low density lipoproteins (LDL) to oxidative modification as well as on the accumulation of lipids in THP-1 derived macrophages. Aliquots of LDL were incubated with copper sulfate in the absence or presence of MTB. The degrees of oxidative modification of LDL were assessed by examining the relative gel electrophoretic mobility, by measuring the amount of thiobarbituric acid reactive substances (TBARS), and by continuous monitoring of the formation of conjugated dienes upon the increase in absorbency at 234 nm. MTB at concentrations of 1–10 μM significantly inhibited oxidative modification of LDL. Such inhibitory effect resulted in a decrease in the uptake of LDL by THP-1 derived macrophages. Taken together, these results clearly demonstrate that MTB inhibits oxidative modification of LDL and hence prevents the uptake of LDL by cultured macrophages. Such effect may be therapeutically relevant in protecting cells from lipid peroxidation in vascular disorders.
Persistent Identifierhttp://hdl.handle.net/10722/224114
ISSN
2023 Impact Factor: 5.2
2023 SCImago Journal Rankings: 1.257
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorO, K-
dc.contributor.authorLynn, EG-
dc.contributor.authorVazhappilly, R-
dc.contributor.authorAu Yeung, KKW-
dc.contributor.authorZhu, DY-
dc.contributor.authorSiow, YL-
dc.date.accessioned2016-03-24T02:40:51Z-
dc.date.available2016-03-24T02:40:51Z-
dc.date.issued2001-
dc.identifier.citationLife Sciences, 2001, v. 68 n. 8, p. 903-912-
dc.identifier.issn0024-3205-
dc.identifier.urihttp://hdl.handle.net/10722/224114-
dc.description.abstractDanshen, a Chinese herbal medicine has been widely used for the treatment of cardiovascular diseases. Magnesium tanshinoate B (MTB) is an active compound purified from Danshen. The objective of this study was to investigate the effect of MTB on the susceptibility of low density lipoproteins (LDL) to oxidative modification as well as on the accumulation of lipids in THP-1 derived macrophages. Aliquots of LDL were incubated with copper sulfate in the absence or presence of MTB. The degrees of oxidative modification of LDL were assessed by examining the relative gel electrophoretic mobility, by measuring the amount of thiobarbituric acid reactive substances (TBARS), and by continuous monitoring of the formation of conjugated dienes upon the increase in absorbency at 234 nm. MTB at concentrations of 1–10 μM significantly inhibited oxidative modification of LDL. Such inhibitory effect resulted in a decrease in the uptake of LDL by THP-1 derived macrophages. Taken together, these results clearly demonstrate that MTB inhibits oxidative modification of LDL and hence prevents the uptake of LDL by cultured macrophages. Such effect may be therapeutically relevant in protecting cells from lipid peroxidation in vascular disorders.-
dc.languageeng-
dc.publisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/lifescie-
dc.relation.ispartofLife Sciences-
dc.rightsPosting accepted manuscript (postprint): © <year>. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subjectFoam cells-
dc.subjectLow density lipoproteins (LDL)-
dc.subjectMacrophages-
dc.subjectMagnesium tanshinoate B (MTB)-
dc.subjectOxidation-
dc.subject.meshAntioxidants - pharmacology-
dc.subject.meshDrugs, Chinese Herbal - pharmacology-
dc.subject.meshLipoproteins, LDL - metabolism - pharmacokinetics-
dc.subject.meshMagnesium - pharmacology-
dc.subject.meshPhenanthrolines - pharmacology-
dc.titleMagnesium tanshinoate B (MTB) inhibits low density lipoprotein oxidation-
dc.typeArticle-
dc.identifier.emailO, K: okarmin@hkucc.hku.hk-
dc.identifier.emailSiow, YL: cylsiow@hkusua.hku.hk-
dc.identifier.doi10.1016/S0024-3205(00)00989-9-
dc.identifier.pmid11213360-
dc.identifier.scopuseid_2-s2.0-0035846880-
dc.identifier.hkuros58908-
dc.identifier.volume68-
dc.identifier.issue8-
dc.identifier.spage903-
dc.identifier.epage912-
dc.identifier.isiWOS:000166536500006-
dc.publisher.placeUnited States-
dc.identifier.issnl0024-3205-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats